Blood pressure as a potential biomarker of the efficacy angiogenesis inhibitor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Blood pressure as a potential biomarker of the efficacy angiogenesis inhibitor

Published:2009-02 Issue:2 Volume:20 Page:200-203
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Lévy B.I.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/20/2/200/396030/mdp018.pdf

Reference38 articles.

1. Angiogenesis inhibitors and hypertension: an emerging issue;Sica;J Clin Oncol,2006

2. Home blood-pressure monitoring in patients receiving sunitinib;Azizi;N Engl J Med,2008

3. Arterial hypertension correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumab;Scartozzi;Ann Oncol,2009

4. Manipulating angiogenesis: from basic science to the bedside;Pepper;Arterioscler Thromb Vasc Biol,1997

5. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis;Hanahan;Cell,1996

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Insights in Early Detection of Anticancer Drug-Related Cardiotoxicity Using Perfusion and Metabolic Imaging;Frontiers in Cardiovascular Medicine;2022-02-07

2. Experience with Sunitinib in metastatic renal cell carcinoma (mRCC) patients: pooled analysis from 3 Spanish observational prospective studies;Expert Opinion on Drug Safety;2017-08-28

3. Validation of a Simple Scoring System to Predict Sorafenib Effectiveness in Patients with Hepatocellular Carcinoma;Targeted Oncology;2017-08-03

4. Regular Physical Activity Increases the Systolic Blood Pressure Response to Acute Caffeine Ingestion in Nonhabitual Caffeine Consumers;Journal of Caffeine Research;2017-06

5. Sunitinib in the treatment of gastrointestinal stromal tumor: patient selection and perspectives;OncoTargets and Therapy;2016-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3